# Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir

> **NCT01577069** · — · COMPLETED · sponsor: **Association HGE CHU Bordeaux Sud** · enrollment: 73 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01577069
- **Lead sponsor:** Association HGE CHU Bordeaux Sud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2016-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01577069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01577069, "Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01577069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*